Nebraska Medicine names chief transformation and digital officer
Nebraska Medicine is proud to welcome nationally recognized leader Michael Hasselberg, PhD, to a new role for the organization: chief transformation and digital officer.
Dr. Hasselberg brings a wealth of experience at the intersection of clinical care, digital innovation and academic research to Nebraska Medicine. His tenure begins Monday, Sept. 1.
Dr. Hasselberg spent his career at the University of Rochester Medicine in New York. He began as a nursing assistant, before working as an inpatient nurse while he pursued a degree as a nurse practitioner. He would later go on to earn a PhD in health practice research. Recently, his roles centered on research and innovation.
He's most excited about joining a team that’s proven to be extraordinary.
“I’ve spent a lot of time traveling this country and seeing lots of different health systems, different industries and organizations. What you have at Nebraska Medicine is absolutely special,” Dr. Hasselberg says. “The people, the mission, Project Health – the innovative approach of that alone is a once-in-a-lifetime opportunity to shape the academic health care of the future. I am humbled to be part of this team.”
“Dr. Hasselberg is a nationally recognized, innovative thought leader with a proven track record in advancing artificial intelligence, rural health, behavioral science, entrepreneurship and clinical research,” says Michael Ash, MD, Nebraska Medicine CEO. “His collaborative approach and visionary leadership are a perfect match for our mission. We are excited for the transformational impact his expertise will bring.”
Dr. Hasselberg currently serves as chief digital health officer at the University of Rochester Medicine, where he also co-directs the UR Health Lab, the system’s digital innovation incubator. A professor of psychiatry, clinical nursing and data science, he was recognized by Rock Health as one of the “Top 50 in Digital Health” for his work advancing health equity through technology during the COVID-19 pandemic.